HyperLab
Service Introduction
Curious about the AI platform that became a hot topic at AACR and DDC?
Drug Discovery

AI Drug Discovery with Hyper Lab: “9x Higher Screening Success Rate, 90% Faster Development Time”

AI Drug Discovery: From 5 Years to Just 3 Months—Discovering a 100nM Active Compound with Hyper Lab
Co-founders
Jaechang Lim, CTO
2025.01.143min read
drug-discovery-ai-hyperlab

Drug discovery is one of the most resource-intensive processes in the pharmaceutical industry. Today, we’ll explore how the AI-powered platform, Hyper Lab, is transforming drug development and creating new possibilities for pharmaceutical research.

Key Achievements of AI Drug Discovery with Hyper Lab

  • 90% Reduction in Development Time: A task that traditionally took 5 years to complete was achieved in just 3 months.

  • 9x Increase in Screening Success Rate: The Hit ratio improved from the typical 1% to approximately 9%.

  • 2x Improvement in Drug Activity Prediction Accuracy: Hyper Lab’s predictions show more than twice the correlation between experimental results and predicted values compared to traditional methods.

     

Success Stories with Hyper Lab in AI Drug Discovery

“Discovering a 100nM Active Compound in Just 3 Months with AI Drug Discovery on Hyper Lab”

At a leading cancer research center in Houston, USA, the institution successfully identified a 100nM active compound just three months after subscribing to Hyper Lab. Previously, after five years of attempts, the team was unable to achieve sub-µM activity. However, after using Hyper Lab, they achieved excellent results from their first design, with one compound showing exceptional activity at 60nM. This case demonstrates Hyper Lab’s high accuracy and highlights its potential to drive groundbreaking outcomes in drug discovery.

hyperlab-case-study

hyperlab-case-study-md-anderson


“9x Higher Screening Success Rate with AI Drug Discovery on Hyper Lab”

In the early stages of drug discovery, screening for active compounds is crucial. Traditional docking-based screening methods have a hit ratio of only about 1%. Hyper Lab increases this ratio to 9%, significantly reducing the risk of experimental failure and enhancing the chances of success in drug development projects. Not only does it improve the hit rate, but Hyper Lab also identified active compounds in the tens of nM range, making it an effective tool for early-stage drug discovery.

screening-hyperlab
Virtual screening of 1M compounds in just 24 hours with Hyper Lab, yielding a 9% hit rate, which IC 50 values ranging from 70 to 600 nM and GI 50 values under 10µM

 

“Doubling the Accuracy of Drug Activity Prediction with AI Drug Discovery on Hyper Lab”

Accurate drug activity prediction is critical in the early stages of AI-driven drug discovery. Traditionally, docking software has been used, but Hyper Lab demonstrates twice the accuracy compared to traditional methods (higher correlation between predicted and experimental values). It has shown high correlation for various protein targets, making it a valuable tool for optimizing activity down to the tens of nM level.

 

docking-hyperlab

correlation-hyperlab

“Overcoming the Limitations of Traditional Platforms with AI Drug Discovery to Create New Compound Structures”

Designing novel chemical modifications based on scaffolds is a critical aspect of drug discovery. Researchers from the Czech Republic have shared their positive experiences with Hyper Lab, noting that it excels at suggesting effective new chemical modifications compared to traditional platforms.

"Hyper Lab was incredibly intuitive and easy to use. Other platforms I’ve used often struggled to effectively suggest novel chemical modifications, and the options they provided were quite limited. In contrast, Hyper Lab offered a much more comprehensive and effective approach, exceeding my expectations in this critical area."

 

Key Technologies in AI Drug Discovery on Hyper Lab

  • Hyper Binding:

    • Drug-activity prediction based on protein 3D structures

  • Hyper Design:

    • Scaffold-based design of novel molecular structures

  • Hyper ADME/T:

    • Predicts 19 in vitro ADME/T properties

  • Hyper Screening:

    • Screens 1 million molecules within 24 hours

The Future of AI Drug Discovery with Hyper Lab

Building on proven success in global research institutions, Hyper Lab is transforming the paradigm of AI-driven drug discovery. With its 9x higher screening success rate, 2x improvement in prediction accuracy, and 90% reduction in development time, Hyper Lab demonstrates the value it offers to the pharmaceutical industry.

Hyper Lab will continue to listen to customer needs and provide innovative, practical AI solutions to maximize drug discovery efficiency. Start using Hyper Lab today and be a part of the next breakthrough in drug development.

 

Free Trial: https://abit.ly/u8z9b2

Contact us: https://abit.ly/6tr1uz

View List